Literature DB >> 25174483

[Impacts of atorvastatin on blood lipids and arterial media thickness in new-onset type 2 diabetes patients].

Dongni Yu1, Yao Wang2, Jiamin Chi1, Mingxiao Sun1, Lixin Guo1, Lei Jiang1, Ming Li1, Hui Li1, Qi Pan1, Xiaoxia Wang1, Tongzhang Xian1.   

Abstract

OBJECTIVE: To analyze the impact of atorvastatin on blood lipids and arterial media thickness (IMT) in new-onset type 2 diabetes patients.
METHODS: 333 patients, 30-70 years old and diagnosed within one year as type 2 diabetes, were selected from the Chinese Diabetes Complication Prevention Study (CDCPS) to take part in this study. Changes of blood lipids and IMT of carotid, femoral and iliac artery pre and post the administration of atorvastatin were tested and followed for 24 months.
RESULTS: Total cholesterol, triglycerides and low-density lipoprotein decreased significantly (P = 0.000) and maintained at a low level. The carotid artery IMT decreased significantly (P = 0.022) at the end of this study, but the femoral and iliac artery IMT did not show any obvious change. There were no serious adverse events noticed, during the study period.
CONCLUSION: Long-term use of atorvastatin seemed to be safe and effective in reducing blood lipids in patients with type 2 diabetes thus could delay the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25174483

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  2 in total

1.  Efficacy and adverse reaction to different doses of atorvastatin in the treatment of type II diabetes mellitus.

Authors:  Hua Jiang; Hong Zheng
Journal:  Biosci Rep       Date:  2019-07-05       Impact factor: 3.840

Review 2.  Atorvastatin Treatment for Carotid Intima-Media Thickness in Chinese Patients With Type 2 Diabetes: A Meta-Analysis.

Authors:  Na Fang; Wei Han; Dandan Gong; Yu Fan
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.